NM_032638.5:c.1359G>A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2

The NM_032638.5(GATA2):​c.1359G>A​(p.Leu453Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,461,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L453L) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000062 ( 0 hom. )

Consequence

GATA2
NM_032638.5 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.37

Publications

0 publications found
Variant links:
Genes affected
GATA2 (HGNC:4171): (GATA binding protein 2) This gene encodes a member of the GATA family of zinc-finger transcription factors that are named for the consensus nucleotide sequence they bind in the promoter regions of target genes. The encoded protein plays an essential role in regulating transcription of genes involved in the development and proliferation of hematopoietic and endocrine cell lineages. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Mar 2009]
GATA2 Gene-Disease associations (from GenCC):
  • deafness-lymphedema-leukemia syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • GATA2 deficiency with susceptibility to MDS/AML
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • monocytopenia with susceptibility to infections
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • acute myeloid leukemia
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • myelodysplastic syndrome
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 3-128481103-C-T is Benign according to our data. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-128481103-C-T is described in CliVar as Likely_benign. Clinvar id is 241717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAdExome4 at 9 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GATA2NM_032638.5 linkc.1359G>A p.Leu453Leu synonymous_variant Exon 6 of 6 ENST00000341105.7 NP_116027.2 P23769-1
GATA2NM_001145661.2 linkc.1359G>A p.Leu453Leu synonymous_variant Exon 7 of 7 NP_001139133.1 P23769-1
GATA2NM_001145662.1 linkc.1317G>A p.Leu439Leu synonymous_variant Exon 6 of 6 NP_001139134.1 P23769-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GATA2ENST00000341105.7 linkc.1359G>A p.Leu453Leu synonymous_variant Exon 6 of 6 1 NM_032638.5 ENSP00000345681.2 P23769-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000616
AC:
9
AN:
1461348
Hom.:
0
Cov.:
31
AF XY:
0.00000825
AC XY:
6
AN XY:
726896
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33476
American (AMR)
AF:
0.00
AC:
0
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26072
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86180
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53394
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
9.00e-7
AC:
1
AN:
1111700
Other (OTH)
AF:
0.000116
AC:
7
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Inborn genetic diseases Benign:1
Mar 27, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Deafness-lymphedema-leukemia syndrome;C3280030:Monocytopenia with susceptibility to infections Benign:1
Oct 14, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
8.6
DANN
Benign
0.68
PhyloP100
1.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs878855168; hg19: chr3-128199946; API